• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-羟色胺自身受体对改变5-羟色胺突触可利用性药物反应的敏感性。

Sensitivity of the response of 5-HT autoreceptors to drugs modifying synaptic availability of 5-HT.

作者信息

Moret C, Briley M

机构信息

Department of Biochemical Pharmacology, Pierre Fabre Research Centre, Castres, France.

出版信息

Neuropharmacology. 1988 Jan;27(1):43-9. doi: 10.1016/0028-3908(88)90199-2.

DOI:10.1016/0028-3908(88)90199-2
PMID:2965314
Abstract

The effect of midalcipran, an equipotent inhibitor of the uptake of 5-hydroxytryptamine (5-HT) and noradrenaline (NA), on the inhibition of release of 5-HT induced by lysergic acid diethylamide (LSD), was investigated by studying the overflow of transmitter from slices of hypothalamus from the rat prelabelled with [3H]5-HT. The (Z)-enantiomer of midalcipran, at 0.1 microM, displaced to the right the concentration-effect curve of inhibition of release of [3H]5-HT elicited by electrical stimulation induced by LSD. In contrast, the (E)-enantiomer, which does not inhibit the uptake of monoamines, was devoid of any antagonizing effect. The inhibitory effect of 0.1 microM LSD was not modified in the presence of maprotiline, bupropion or mianserin at 1 microM. The results of this study show that the interaction between the 5-HT autoreceptor and the inhibitors of the uptake of 5-HT is related exclusively to their potency at inhibiting the uptake of 5-HT. The effect of the monoamine oxidase inhibitor, pargyline (1-10 microM), was also studied on the field-stimulated release of [3H]5-HT. The inhibitory effect of this drug was antagonized by methiothepin at 0.1 and 1 microM, by phentolamine 1 microM and 10 microM and by the inhibitor of the uptake of 5-HT, citalopram at 0.1 and 1 microM. The action of pargyline appeared to be mediated through the activation of the serotonergic autoreceptor and of the presynaptic alpha-adrenoceptor located on serotonergic nerve terminals. The results obtained with pargyline are consistent with the hypothesis of an interaction between the 5-HT autoreceptor and the uptake site for 5-HT.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

通过研究用[3H]5-羟色胺(5-HT)预标记的大鼠下丘脑切片中递质的溢出情况,研究了米氮平(一种对5-羟色胺(5-HT)和去甲肾上腺素(NA)摄取具有同等效力的抑制剂)对麦角酸二乙酰胺(LSD)诱导的5-HT释放抑制作用的影响。米氮平的(Z)-对映体在0.1微摩尔浓度时,使LSD诱导的电刺激引起的[3H]5-HT释放抑制浓度-效应曲线向右移动。相比之下,不抑制单胺摄取的(E)-对映体则没有任何拮抗作用。在存在1微摩尔浓度的马普替林、安非他酮或米安色林时,0.1微摩尔浓度LSD的抑制作用未改变。本研究结果表明,5-HT自身受体与5-HT摄取抑制剂之间的相互作用仅与其抑制5-HT摄取的效力有关。还研究了单胺氧化酶抑制剂帕吉林(1 - 10微摩尔)对电场刺激的[3H]5-HT释放的影响。该药物的抑制作用在0.1和1微摩尔浓度的甲硫噻平、1微摩尔和10微摩尔浓度的酚妥拉明以及0.1和1微摩尔浓度的5-HT摄取抑制剂西酞普兰存在时被拮抗。帕吉林的作用似乎是通过激活位于5-羟色胺能神经末梢的5-羟色胺能自身受体和突触前α-肾上腺素受体介导的。用帕吉林获得的结果与5-HT自身受体和5-HT摄取位点之间相互作用的假设一致。(摘要截短至250字)

相似文献

1
Sensitivity of the response of 5-HT autoreceptors to drugs modifying synaptic availability of 5-HT.5-羟色胺自身受体对改变5-羟色胺突触可利用性药物反应的敏感性。
Neuropharmacology. 1988 Jan;27(1):43-9. doi: 10.1016/0028-3908(88)90199-2.
2
Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.三环类和非三环类5-羟色胺摄取抑制剂与大鼠下丘脑突触前5-羟色胺抑制性自身受体之间的相互作用。
J Pharmacol Exp Ther. 1985 Oct;235(1):200-11.
3
Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.西酞普兰可拮抗大鼠下丘脑中麦角酸二乙胺对突触前抑制性5-羟色胺自身受体的刺激作用。
J Pharmacol Exp Ther. 1982 Jul;222(1):220-6.
4
Interaction between neuronal uptake inhibitors and presynaptic serotonin autoreceptors in rat hypothalamic slices: comparison of K+ and electrical depolarization.大鼠下丘脑切片中神经元摄取抑制剂与突触前5-羟色胺自身受体之间的相互作用:钾离子和电去极化的比较
J Pharmacol Exp Ther. 1987 Sep;242(3):1056-63.
5
Serotonin autoreceptor subsensitivity and antidepressant activity.血清素自身受体敏感性降低与抗抑郁活性。
Eur J Pharmacol. 1990 May 16;180(2-3):351-6. doi: 10.1016/0014-2999(90)90320-6.
6
Modulation by drugs of the release of total tritium and 3H-5-HT from rat hypothalamic slices.药物对大鼠下丘脑切片中总氚和3H - 5 - 羟色胺释放的调节作用。
Naunyn Schmiedebergs Arch Pharmacol. 1990 May;341(5):398-403. doi: 10.1007/BF00176330.
7
Dihydroergocristine-induced stimulation of the 5-HT autoreceptor in the hypothalamus of the rat.
Neuropharmacology. 1986 Feb;25(2):169-74. doi: 10.1016/0028-3908(86)90038-9.
8
Effects of methiothepin and lysergic acid diethylamide on serotonin release in vitro and serotonin synthesis in vivo: possible relation to serotonin autoreceptor function.甲硫噻吨和麦角酸二乙胺对体外5-羟色胺释放及体内5-羟色胺合成的影响:与5-羟色胺自身受体功能的可能关系。
J Neurochem. 1984 Jul;43(1):83-90. doi: 10.1111/j.1471-4159.1984.tb06681.x.
9
Interaction between serotonin uptake inhibitors and alpha-2 adrenergic heteroreceptors in the rat hypothalamus.大鼠下丘脑5-羟色胺摄取抑制剂与α-2肾上腺素能异受体之间的相互作用。
J Pharmacol Exp Ther. 1990 Jul;254(1):236-44.
10
Demonstration of an autoreceptor modulating the release of [3H]5-hydroxytryptamine from a synaptosomal-rich spinal cord tissue preparation.一种自身受体调节富含突触体的脊髓组织制剂中[3H]5-羟色胺释放的证明。
J Neurochem. 1985 Dec;45(6):1886-94. doi: 10.1111/j.1471-4159.1985.tb10548.x.

引用本文的文献

1
Ex vivo inhibitory effect of the 5-HT uptake blocker citalopram on 5-HT synthesis.5-羟色胺摄取阻滞剂西酞普兰对5-羟色胺合成的体外抑制作用
J Neural Transm (Vienna). 1997;104(2-3):147-60. doi: 10.1007/BF01273177.
2
Proceedings of the British Pharmacological Society. London, 19th-21st December. Abstracts.英国药理学会会议记录。伦敦,12月19日至21日。摘要。
Br J Pharmacol. 1989 Mar;96 Suppl(Suppl):1P-368P.
3
Modulation by drugs of the release of total tritium and 3H-5-HT from rat hypothalamic slices.药物对大鼠下丘脑切片中总氚和3H - 5 - 羟色胺释放的调节作用。
Naunyn Schmiedebergs Arch Pharmacol. 1990 May;341(5):398-403. doi: 10.1007/BF00176330.
4
Serotonin uptake blockers influence serotonin autoreceptors by increasing the biophase concentration of serotonin and not through a "molecular link".血清素摄取阻滞剂通过增加血清素的生物相浓度而非通过“分子连接”来影响血清素自身受体。
Naunyn Schmiedebergs Arch Pharmacol. 1990 Oct;342(4):363-70. doi: 10.1007/BF00169450.